Biodel Inc.Danbury, CT United States
Company Description
Biodel delves into the development of viable treatments for diabetes. The company uses its VIAdel biological technology to reformulate and administer existing peptide hormones (such as insulin) for the treatment of diabetes and its complications including hyper- and hypoglycemia, cardiovascular problems, and weight control. Its two lead product candidates are VIAject, an injectable insulin formulation designed to be rapidly absorbed into the bloodstream, and VIAtab tablets which are administered sublingually (under the tongue). Both candidates are in clinical trials; VIAject is closest to commercialization. Biodel has three other diabetes-related candidates in its pipeline at varying stages of development.
| 100 Saw Mill Rd. | Phone: 203-796-5000 | http://www.biodel.com |
| Danbury, CT 06810 | Fax: 203-796-5001 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Biodel Inc. Rankings
Executives
| 23 executives listed for Biodel Inc.'s Danbury, CT location. | ||
| Chairman | Charles Sanders | |
|---|---|---|
| President, CEO, and Director | Errol De Souza | |
| VP Operations | ErikSteiner | |
Financials
| Company Type | Public - NASDAQ: BIOD Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2011 Employees | 36 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Biodel Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
